Sirona Historical Income Statement
| SBM Stock | CAD 0.07 0.01 13.33% |
Historical analysis of Sirona Biochem income statement accounts such as Other Operating Expenses of 782, Research Development of 1.1 M, Cost Of Revenue of 34.2 K or Non Recurring of 51.8 K can show how well Sirona Biochem Corp performed in making a profits. Evaluating Sirona Biochem income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Sirona Biochem's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Sirona Biochem Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Sirona Biochem Corp is a good buy for the upcoming year.
Sirona |
About Sirona Income Statement Analysis
Sirona Biochem Corp Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Sirona Biochem shareholders. The income statement also shows Sirona investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Sirona Biochem Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Sirona Biochem Corp. It is also known as Sirona Biochem overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Sirona Biochem's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Sirona Biochem Corp current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sirona Biochem Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Sirona Biochem's Interest Expense is fairly stable compared to the past year. Gross Profit is likely to climb to about 220.5 K in 2024, whereas Total Revenue is likely to drop slightly above 38 K in 2024.
| 2023 | 2024 (projected) | Total Operating Expenses | 2.8M | 3.5M | Non Recurring | 54.6K | 51.8K |
Sirona Biochem income statement Correlations
Click cells to compare fundamentals
Sirona Biochem Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Sirona Biochem income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Interest Expense | 13.1K | 3.3K | 27.0K | 201.7K | 231.9K | 243.5K | |
| Selling General Administrative | 3.0M | 1.4M | 2.7M | 930.4K | 1.1M | 1.0M | |
| Total Revenue | 105.7K | 268.0K | 671.9K | 34.8K | 40.0K | 38.0K | |
| Operating Income | (4.2M) | (2.3M) | (3.5M) | (2.4M) | (2.2M) | (2.3M) | |
| Net Income From Continuing Ops | (4.1M) | (2.3M) | (3.6M) | (2.5M) | (2.3M) | (2.4M) | |
| Ebit | (4.2M) | (4.0M) | (2.1M) | (3.4M) | (3.1M) | (3.2M) | |
| Research Development | 1.3M | 1.2M | 1.1M | 1.2M | 1.4M | 1.1M | |
| Total Operating Expenses | 4.3M | 2.6M | 4.2M | 2.4M | 2.8M | 3.5M | |
| Income Before Tax | (4.1M) | (2.3M) | (3.6M) | (2.5M) | (2.3M) | (2.4M) | |
| Total Other Income Expense Net | 1.6K | (11.9K) | 12.6K | 63.4K | 72.9K | 76.5K | |
| Net Income Applicable To Common Shares | (4.5M) | (4.1M) | (2.3M) | (3.6M) | (3.2M) | (3.4M) | |
| Net Income | (4.1M) | (2.3M) | (3.6M) | (2.5M) | (2.3M) | (2.4M) | |
| Income Tax Expense | (6.2K) | (7.1K) | (5.7K) | 6.0K | 6.8K | 8.5K | |
| Net Interest Income | 27.5K | (3.3K) | (27.0K) | (201.7K) | (231.9K) | (220.3K) | |
| Tax Provision | (7.1K) | (5.7K) | 6.0K | (954.0) | (858.6) | (815.67) | |
| Ebitda | (4.4M) | (4.1M) | (2.3M) | (3.5M) | (3.2M) | (3.3M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Sirona Stock Analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.